Possible influence of the mutant CCR5 allele on vertical transmission of HIV-1

被引:0
|
作者
Mandl, CW [1 ]
Aberle, SW [1 ]
Henkel, JH [1 ]
Puchhammer-Stöckl, E [1 ]
Heinz, FX [1 ]
机构
[1] Univ Vienna, Inst Virol, A-1095 Vienna, Austria
关键词
co-receptor CCR5; vertical transmission; resistance to HIV-1;
D O I
10.1002/(SICI)1096-9071(199805)55:1<51::AID-JMV9>3.3.CO;2-Q
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A possible correlation between the rate of vertical transmission of HIV-1 and the presence of the defective HIV co-receptor gene Delta 32ccr5 in the chromosomes of infants born to HIV-positive mothers was assessed. The prevalence and genotypic distribution of the Delta 32ccr5 gene were studied in 451 uninfected and 225 HIV-l-infected adults and 79 children born to HIV-1-positive mothers in Austria (45 uninfected and 34 infected by vertical transmission). As expected in a Caucasian population, the Delta 32ccr5 allele was found in uninfected Austrians at a frequency of 10% (17.3% heterozygotes and 1.3% Delta 32ccr5/Delta 32ccr5 homozygotes, consistent with the expected Hardy-Weinberg distribution). The mutant allele frequency was 11.1% in uninfected children (17.8% heterozygotes, 2.2% homozygotes) and 9.6% in HIV-positive adults (19.1% heterozygotes but no Delta 32ccr5/Delta 32ccr5 homozygotes). Among the group of 34 vertically infected children, however, there were only two heterozygotes and no Delta 32ccr5/Delta 32ccr5 homozygotes, corresponding to a significantly reduced mutant allele frequency of 2.9% (P = 0.05 compared to HIV-negative children). These results suggest that CCR5/Delta 32ccr5 heterozygous children are less susceptible to vertical transmission of HIV-1. The data also support the hypothesis that Delta 32ccr5 homozygous individuals are resistant to HIV-1 infection. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 50 条
  • [21] Choosing CCR5 or Rev siRNA in HIV-1
    H. Jose Arteaga
    Jorma Hinkula
    Iris van Dijk-Härd
    M. Sirac Dilber
    Britta Wahren
    Birger Christensson
    Abdalla J. Mohamed
    C. I. Edvard Smith
    [J]. Nature Biotechnology, 2003, 21 : 230 - 231
  • [22] HIV-1 infection and CCR5Δ32 homozygosis
    Ballana, Ester
    Este, Jose A.
    [J]. FUTURE VIROLOGY, 2012, 7 (07) : 653 - 658
  • [23] CCR5 as target for HIV-1 gene therapy
    Nazari, Reza
    Joshi, Sadhna
    [J]. CURRENT GENE THERAPY, 2008, 8 (04) : 264 - 272
  • [24] CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
    Oh, Djin-Ye
    Jessen, Heiko
    Kuecherer, Claudia
    Neumann, Konrad
    Oh, Nari
    Poggensee, Gabriele
    Bartmeyer, Barbara
    Jessen, Arne
    Pruss, Axel
    Schumann, Ralf R.
    Hamouda, Osamah
    [J]. PLOS ONE, 2008, 3 (07):
  • [25] Detection of New Mutant Sites of HIV-1 Coreceptor CCR5 Among Saudi Populations
    Abuelsaad, Abdelaziz S. A.
    Al-Ghamdi, Abdullhamid S.
    Al-Ghamdi, Ahmed N.
    Alakkas, Eyad A.
    Alsulaimani, Adnan A.
    Al-Harthi, Abdulla A.
    Abdel-Moneim, Ahmed S.
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2013, 33 (12): : 783 - 789
  • [26] Protective Effect of CCR5 Delta-32 Allele Against HIV-1 in Mexican Women
    Estrada-Aguirre, Jesus A.
    Cazarez-Salazar, Silvestre G.
    Ochoa-Ramirez, Luis A.
    Acosta-Cota, Selene de J.
    Zamora-Gomez, Roman
    Najar-Reyes, Guilermi M.
    Villarreal-Escamilla, Perla
    Osuna-Ramirez, Ignacio
    Diaz-Camacho, Sylvia P.
    Sanchez-Zazueta, Jorge G.
    Rios-Tostado, Juan J.
    Velarde-Felix, Jesus S.
    [J]. CURRENT HIV RESEARCH, 2013, 11 (06) : 506 - 510
  • [27] Distribution of CCR-5 Δ32 allele in Argentinian children at risk of HIV-1 infection:: its role in vertical transmission
    Mangano, A
    Prada, F
    Roldán, A
    Picchio, G
    Bologna, R
    Sen, L
    [J]. AIDS, 1998, 12 (01) : 109 - 110
  • [28] How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infection
    van Lunzen, Jan
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (09) : 435 - 440
  • [29] Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
    Mohamed, Hager
    Gurrola, Theodore
    Berman, Rachel
    Collins, Mackenzie
    Sariyer, Ilker K.
    Nonnemacher, Michael R.
    Wigdahl, Brian
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [30] Prevalence of mutant CCR5 allele in Slovenian HIV-1-infected and non-infected individuals
    Poljak, M
    Tomazic, J
    Seme, K
    Maticic, M
    Vidmar, L
    [J]. ACTA VIROLOGICA, 1998, 42 (01) : 23 - 26